Dashboard
Manage Tickers

HROW HARROW, INC.

Nasdaq harrowinc.com


$ 38.80 $ 0.45 (1.17 %)    

Friday, 24-Oct-2025 09:41:00 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 617.05 $ 1.07 (0.17 %)
DIA $ 470.53 $ 0.66 (0.14 %)
SPY $ 677.11 $ 0.66 (0.1 %)
TLT $ 91.50 $ -0.10 (-0.11 %)
GLD $ 377.37 $ -1.14 (-0.3 %)
$ 39.04
$ 38.35
$ 38.70 x 33
$ 38.91 x 9
$ 37.85 - $ 38.80
$ 20.85 - $ 55.75
258,745
na
1.44B
$ 1.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-11-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 03-27-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-13-2024 03-31-2024 10-Q
7 03-19-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-23-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 03-10-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-10-2021 06-30-2021 10-Q
18 05-11-2021 03-31-2021 10-Q
19 03-08-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 03-13-2020 12-31-2019 10-K
24 11-13-2019 09-30-2019 10-Q
25 08-14-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 03-12-2019 12-31-2018 10-K
28 11-13-2018 09-30-2018 10-Q
29 08-06-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 03-08-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 08-10-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-21-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
37 08-15-2016 06-30-2016 10-Q
38 05-12-2016 03-31-2016 10-Q
39 03-23-2016 12-31-2015 10-K
40 11-12-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

b-riley-securities-reiterates-buy-on-harrow-raises-price-target-to-74
B. Riley Securities Reiterates Buy on Harr...
10/01/2025 14:40:19

B. Riley Securities analyst Mayank Mamtani reiterates Harrow (NASDAQ:HROW) with a Buy and raises the price target from $70 t...

lake-street-maintains-buy-on-harrow-raises-price-target-to-70
Lake Street Maintains Buy on Harrow, Raise...
09/29/2025 14:32:53

Lake Street analyst Thomas Flaten maintains Harrow (NASDAQ: HROW) with a Buy and raises the price target from $42 to $70.

hc-wainwright--co-reiterates-buy-on-harrow-maintains-64-price-target
HC Wainwright & Co. Reiterates Buy on Harr...
09/29/2025 10:27:32

HC Wainwright & Co. analyst Yi Chen reiterates Harrow (NASDAQ: HROW) with a Buy and maintains $64 price target.

btig-reiterates-buy-on-harrow-maintains-63-price-target
BTIG Reiterates Buy on Harrow, Maintains $...
09/29/2025 10:06:11

BTIG analyst Thomas Shrader reiterates Harrow (NASDAQ: HROW) with a Buy and maintains $63 price target.

could-harrows-new-sedation-pill-change-millions-of-medical-procedures-forever
Could Harrow's New Sedation Pill Change Mi...
09/26/2025 12:57:39

Harrow, Inc. (NASDAQ: HROW), a U.S.-based provider of ophthalmic disease management solutions, announced on Friday that it has ...

harrow-to-acquire-melt-pharma-advancing-sublingual-sedation-therapy-melt-300-toward-2027-nda-after-positive-phase-3-results
Harrow To Acquire Melt Pharma, Advancing S...
09/26/2025 11:03:39

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it ...

demystifying-harrow-insights-from-5-analyst-reviews
Demystifying Harrow: Insights From 5 Analy...
09/23/2025 20:01:43

b-riley-securities-maintains-buy-on-harrow-raises-price-target-to-70
B. Riley Securities Maintains Buy on Harro...
09/23/2025 17:50:07

B. Riley Securities analyst Mayank Mamtani maintains Harrow (NASDAQ:HROW) with a Buy and raises the price target from $65 to...

tesla-to-rally-around-4-here-are-10-top-analyst-forecasts-for-tuesday
Tesla To Rally Around 4%? Here Are 10 Top ...
09/23/2025 15:37:15

craig-hallum-maintains-buy-on-harrow-raises-price-target-to-64
Craig-Hallum Maintains Buy on Harrow, Rais...
09/23/2025 13:51:55

Craig-Hallum analyst Chase Knickerbocker maintains Harrow (NASDAQ:HROW) with a Buy and raises the price target from $54 to $64.

btig-maintains-buy-on-harrow-raises-price-target-to-63
BTIG Maintains Buy on Harrow, Raises Price...
08/14/2025 12:17:13

BTIG analyst Thomas Shrader maintains Harrow (NASDAQ:HROW) with a Buy and raises the price target from $62 to $63.

hc-wainwright--co-maintains-buy-on-harrow-raises-price-target-to-64
HC Wainwright & Co. Maintains Buy on Harro...
08/13/2025 12:01:08

HC Wainwright & Co. analyst Yi Chen maintains Harrow (NASDAQ:HROW) with a Buy and raises the price target from $60 to $64.

harrow-fy2025--revenue-expected-to-be-more-than-280000m-vs-283545m-est
Harrow FY2025 Revenue expected to be more...
08/11/2025 20:02:32

Harrow (NASDAQ:HROW) FY2025 Revenue expected to be more than $280.000M vs $283.545M Est

harrow-q2-adj-eps-024-beats-001-estimate-sales-63742m-miss-65234m-estimate
Harrow Q2 Adj. EPS $0.24 Beats $0.01 Estim...
08/11/2025 20:01:35

Harrow (NASDAQ:HROW) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.01 by 2081....

Core News & Articles
Earnings Scheduled For August 11, 2025
08/11/2025 08:32:28

a-preview-of-harrows-earnings
A Preview Of Harrow's Earnings
08/08/2025 15:05:42

Core News & Articles
Harrow Secures US Rights to Two Vision-Sav...
07/17/2025 11:05:05

Harrow (NASDAQ:HROW), a leading North American eyecare pharmaceutical company, today announced that it has entered into a defin...

Core News & Articles
10 Health Care Stocks Whale Activity In To...
07/16/2025 17:35:18

this-harrow-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-friday
This Harrow Analyst Begins Coverage On A B...
07/11/2025 16:01:42

cantor-fitzgerald-initiates-coverage-on-harrow-with-overweight-rating-announces-price-target-of-76
Cantor Fitzgerald Initiates Coverage On Ha...
07/11/2025 11:59:02

Cantor Fitzgerald analyst Steve Seedhouse initiates coverage on Harrow (NASDAQ:HROW) with a Overweight rating and announces ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION